Visiongain predicts total revenues the global IVD market will grow from its 2016 level of $61.85bn to $122.9bn by 2027, representing a CAGR of 6.4% during the period 2016 to 2027

30 August 2018
Pharma

A new report by visiongain forecasts the world IVD market will reach $122.9bn in 2027. That revenue prediction and others appear in Medical Devices Leader Series - Top In Vitro Diagnostics (IVD) Companies 2017-2027: Leading IVD Companies in the US, Europe and Asia published in November 2016. Visiongain is a business information publisher and consultancy in London, UK.

Visiongain estimates that in 2016, Big Pharma companies, namely Roche, Danaher and Siemens dominated the sector accounting for 41.5% of the global IVD market with combined revenue of $25.7bn

This report analyses the leading companies operating in the in vitro diagnostics (IVD) market. It aims to provide a comprehensive review of those companies, looking at their IVD products, financial performance, deals with other drug developers and future outlooks. The study examines opportunities and challenges in the industry and market for IVD products, as well as strategies for future growth. To provide context for the company profiles, this report also contains analysis of the world IVD market. An estimate for the market size is provided for 2016, and overall market revenues are forecasted for the period 2017 to 2027. Additionally, there is an analysis of the leading IVD segments.

The report focuses on these main segments of the market:

• Clinical Chemistry
• Immunochemistry
• Haematology
• Microbiology
• Genetic Testing
• Point-of-Care

This 185 page report provides:

• Most recent profiles of top In Vitro Diagnostic American Companies with updated revenues and forecast for the period 2017-2027

• Most recent profiles of top In Vitro Diagnostic European Companies with updated revenues and forecast for the period 2017-2027

• Most recent profiles of top In Vitro Diagnostic Asian Companies with updated revenues and forecast for the period 2017-2027

• Enhanced detail analysis of what stimulates and restrains that industry and market.

• 75 figures and 65 tables.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever